annb0t
Top 20
ResMed Inc.'s RMD adjusted earnings per share (EPS) in the second quarter of fiscal 2023 were $1.66, up 12.9% year over year. The metric also exceeded the Zacks Consensus Estimate by 3.8%.
The adjustments include certain non-recurring expenses/benefits like amortization of acquired intangibles and acquisition-related expenses, among others.
GAAP EPS in the reported quarter was $1.53, up 11.7% from the year-ago quarterâs EPS.
Revenues
Fiscal second-quarter revenues on a reported basis in...
>>> Read more: ResMed's (RMD) Q2 Earnings Beat Estimates, Margins Falls
The adjustments include certain non-recurring expenses/benefits like amortization of acquired intangibles and acquisition-related expenses, among others.
GAAP EPS in the reported quarter was $1.53, up 11.7% from the year-ago quarterâs EPS.
Revenues
Fiscal second-quarter revenues on a reported basis in...
>>> Read more: ResMed's (RMD) Q2 Earnings Beat Estimates, Margins Falls
